Your search history is turned on.
Date: February 7, 2024 Jurisdictions: Ontario
Small Pharma - [Final] Application Letter under Simplified Procedure (Project Centaur - October 2023) Ryan Cohen Direct: 647.426.2307 E-mail: [email protected] October 26, 2023 VIA SEDAR+ PORTAL Ontario Securities Commission 20 Queen Street West, 22nd Floor Toronto, Ontario M5H 3S8 Attention: Applications Administrator Dear...
Microsoft Word - Small Pharma 2023-0528 Final Decision (Conformed Signature) 20231208 Ontario Commission des 22nd Floor 22e tage Securities valeurs mobilires 20 Queen Street West 20, rue queen ouest Commission de lOntario Toronto ON M5H 3S8 Toronto ON M5H 3S8 December 8, 2023 In the Matter of the Securities Legislation of Ontario (the Jurisdiction) an...
Date: January 29, 2024 Jurisdictions: All jurisdictions
Microsoft Word - Form 52-109FV2 - Interim CFO Certificate - Q3 2023 (Small Pharma) _Draft_(55815486.2) Form 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Greg Cavers, Chief Financial Officer of Small Pharma Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the inter...
Microsoft Word - Form 52-109FV2 - Interim CEO Certificate - Q3 2023 (Small Pharma) _Draft_(55815485.2) Form 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, George Tziras, Chief Executive Officer of Small Pharma Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the int...
Microsoft Word - Q3 2023 - MDA (Small Pharma) final(55814032.5) SMALL PHARMA INC. Managements Discussion and Analysis of Financial Condition and Results of Operations As at November 30, 2023 Date: January 29, 2024 2 SMALL PHARMA INC. Managements Discussion and Analysis This Managements Discussion and Analysis (MD&A) has b...
Microsoft Word - Q3 2023 - Interim Financial Statements (Small Pharma) final(55699721.4) SMALL PHARMA INC. Interim Condensed Consolidated Financial Statements November 30, 2023 (Expressed in Canadian Dollars) The accompanying unaudited interim condensed consolidated financial statements of Small Pharma Inc. (the Company) have been prepared by and are ...
Date: October 31, 2023 Jurisdictions: All jurisdictions
Small Pharma- Notice of Change in Corporate Structure-Oct 2023 NOTICE OF CHANGE IN CORPORATE STRUCTURE PURSUANT TO SECTION 4.9 OF NATIONAL INSTRUMENT 51-102 - CONTINUOUS DISCLOSURE OBLIGATIONS 1. Names of Parties to the Transaction: Small Pharma Inc. (Small Pharma) Cybin Inc. (Cybin) 2. Description of the Transaction: On October 23, 2023, Cyb...
Date: October 25, 2023 Jurisdictions: All jurisdictions
Microsoft Word - Project Centaur - Material Change Report (Small Pharma - Oct 2023)(54726523.1) FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Small Pharma Inc. (Small Pharma) 50 Featherstone Street, 1st Floor London, UK EC1Y 8RT Item 2 Date of Material Change October 23, 2023 Item 3 News Release A joint press release betwe...
Date: October 23, 2023 Jurisdictions: All jurisdictions
Microsoft Word - Project Centaur - Closing Press Release Final(54690681.6) Cybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics This news release constitutes a designated news release for the purposes of Cybins prospectus supplements each dated August 23, 2023, to its short form base she...
Date: October 19, 2023 Jurisdictions: All jurisdictions
Small Pharma Reports Fiscal Second Quarter 2024 Highlights Shareholders overwhelmingly vote in favour of Cybins acquisition of Small Pharma, supporting the combined companys vision to build an international clinical-stage leader in psychedelic-based therapeutics LONDON, Oct. 19, 2023 -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the Company or Small Pharma), a biotechnology company focused...